Form 8-K - Current report:
SEC Accession No. 0000950170-24-135207
Filing Date
2024-12-11
Accepted
2024-12-11 07:00:15
Documents
53
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20241211.htm   iXBRL 8-K 62837
2 EX-99.1 rlay-ex99_1.htm EX-99.1 51510
3 EX-99.2 rlay-ex99_2.htm EX-99.2 42932
4 GRAPHIC img175089203_0.jpg GRAPHIC 7375
5 GRAPHIC rlay-ex99_2s1.jpg GRAPHIC 163404
6 GRAPHIC rlay-ex99_2s2.jpg GRAPHIC 665249
7 GRAPHIC rlay-ex99_2s3.jpg GRAPHIC 207506
8 GRAPHIC rlay-ex99_2s4.jpg GRAPHIC 333734
9 GRAPHIC rlay-ex99_2s5.jpg GRAPHIC 341172
10 GRAPHIC rlay-ex99_2s6.jpg GRAPHIC 396856
11 GRAPHIC rlay-ex99_2s7.jpg GRAPHIC 267894
12 GRAPHIC rlay-ex99_2s8.jpg GRAPHIC 249178
13 GRAPHIC rlay-ex99_2s9.jpg GRAPHIC 213231
14 GRAPHIC rlay-ex99_2s10.jpg GRAPHIC 336451
15 GRAPHIC rlay-ex99_2s11.jpg GRAPHIC 313007
16 GRAPHIC rlay-ex99_2s12.jpg GRAPHIC 385218
17 GRAPHIC rlay-ex99_2s13.jpg GRAPHIC 303866
18 GRAPHIC rlay-ex99_2s14.jpg GRAPHIC 354138
19 GRAPHIC rlay-ex99_2s15.jpg GRAPHIC 352253
20 GRAPHIC rlay-ex99_2s16.jpg GRAPHIC 321089
21 GRAPHIC rlay-ex99_2s17.jpg GRAPHIC 342297
22 GRAPHIC rlay-ex99_2s18.jpg GRAPHIC 357026
23 GRAPHIC rlay-ex99_2s19.jpg GRAPHIC 340058
24 GRAPHIC rlay-ex99_2s20.jpg GRAPHIC 335357
25 GRAPHIC rlay-ex99_2s21.jpg GRAPHIC 298716
26 GRAPHIC rlay-ex99_2s22.jpg GRAPHIC 340121
27 GRAPHIC rlay-ex99_2s23.jpg GRAPHIC 342656
28 GRAPHIC rlay-ex99_2s24.jpg GRAPHIC 266976
29 GRAPHIC rlay-ex99_2s25.jpg GRAPHIC 212448
30 GRAPHIC rlay-ex99_2s26.jpg GRAPHIC 283057
31 GRAPHIC rlay-ex99_2s27.jpg GRAPHIC 208746
32 GRAPHIC rlay-ex99_2s28.jpg GRAPHIC 358966
33 GRAPHIC rlay-ex99_2s29.jpg GRAPHIC 247834
34 GRAPHIC rlay-ex99_2s30.jpg GRAPHIC 249274
35 GRAPHIC rlay-ex99_2s31.jpg GRAPHIC 330354
36 GRAPHIC rlay-ex99_2s32.jpg GRAPHIC 365623
37 GRAPHIC rlay-ex99_2s33.jpg GRAPHIC 340147
38 GRAPHIC rlay-ex99_2s34.jpg GRAPHIC 359224
39 GRAPHIC rlay-ex99_2s35.jpg GRAPHIC 290262
40 GRAPHIC rlay-ex99_2s36.jpg GRAPHIC 282461
41 GRAPHIC rlay-ex99_2s37.jpg GRAPHIC 302323
42 GRAPHIC rlay-ex99_2s38.jpg GRAPHIC 107261
43 GRAPHIC rlay-ex99_2s39.jpg GRAPHIC 426182
  Complete submission text file 0000950170-24-135207.txt   17091292

Data Files

Seq Description Document Type Size
44 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20241211.xsd EX-101.SCH 23863
55 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20241211_htm.xml XML 4526
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 241540119
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)